Clinical Trials Directory

Trials / Unknown

UnknownNCT04101162

NAFLD Study: US vs Liver Biopsy

Diagnostic Accuracy in a New Ultrasound Software Compared to Histology for Non Alcoholic Fatty Liver Disease (NAFLD) and Non Alcoholic Steato Hepatitis (NASH) in Morbidly Obese Individuals Undergoing Bariatic Surgery and/or Cholecystectomy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
University of Roma La Sapienza · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Evaluate the diagnostic accuracy of the new ultrasound software vs hepatic histology, the current reference standard for the diagnosis of NAFLD and NASH in 20 obese patients (BMI\> 30) candidates for laparoscopic bariatric surgery and / or cholecystectomy

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTshear waves elastography; liver biopsyDiagnostic accuracy in a new ultrasound software compared to histology for Non Alcoholic Fatty liver disease (NAFLD) and Non Alcoholic Steato Hepatitis (NASH)

Timeline

Start date
2019-09-15
Primary completion
2020-10-15
Completion
2020-12-15
First posted
2019-09-24
Last updated
2020-04-01

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04101162. Inclusion in this directory is not an endorsement.

NAFLD Study: US vs Liver Biopsy (NCT04101162) · Clinical Trials Directory